This collection of endocrinology thesis topics for MD Medicine supports MD and DNB General Medicine residents studying diabetes, thyroid disease, obesity, metabolic bone disorders, adrenal and pituitary disease, and reproductive endocrine problems. These endocrinology research topics for medicine residents can be shaped into projects completable within one thesis period using patients and investigations already available in medicine clinics, wards and collaborating endocrine units, after confirming recruitment and assay access. Routine biochemical testing and focused clinical assessments support many feasible questions, with specialised investigations included only where resources are established. Each selected question should be developed into an endocrinology protocol for MD Medicine and an institution-specific endocrinology synopsis for medicine residents.
Last reviewed and updated: September 2026 · 2026–27 admissions
Our MD Medicine Thesis Guidance provides structured protocols, sample size formulas, and institutional review board (IRB) layout guides.
Looking for premium Endocrinology thesis topics for your DM? Or the full medicine collection across all sections? Updated September 2026.
📌 Updated for 2026–2027 MD and DNB Medicine admissions: Endocrinology
The accompanying guidance has been reviewed for hormone-sampling conditions, assay interference, treatment status and the validity of glycaemic and endocrine outcome measurements.
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
Already have your thesis title?
Generate the full endocrinology protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocolAlongside endocrinology protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →Endocrinology research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the endocrinology research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the endocrinology research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare an endocrinology research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A endocrinology IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning endocrinology research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the endocrinology research proposal is the document assessed at the start of it.
Kuwait — KIMS. A endocrinology study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the endocrinology proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A endocrinology dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full endocrinology research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about an endocrinology PhD or MMed proposal →🔥 Trending research areas in Endocrinology for 2026–27
Define the endocrine state. Specify diagnostic criteria, assay-dependent thresholds and whether participants are newly diagnosed, untreated, stable on therapy or undergoing a treatment change. Distinguish a biochemical abnormality from a confirmed endocrine disorder and state when confirmation is required. Acute illness can alter endocrine measurements, so define whether recruitment occurs during acute admission or clinical stability.
Standardise sampling conditions. Record collection time, fasting status where relevant, menstrual or reproductive context, pregnancy status, acute stress and the timing of medicines. Cortisol and reproductive hormone studies need a sampling plan appropriate to the physiological question. For dynamic testing, specify the validated procedure, sampling schedule, interpretive method and supervising clinician; do not withdraw necessary treatment merely to simplify research measurements.
Identify interference before analysis. Record assay platform, units, reference intervals, quality controls and relevant supplements. Biotin can distort susceptible thyroid immunoassays; a discrepant result requires laboratory review rather than automatic classification as thyroid disease. The American Thyroid Association discussion of biotin interference illustrates why supplement history matters. Any testing adjustment should follow laboratory and clinical advice.
Match the marker to the outcome. Define how glucose, HbA1c, symptom scores, anthropometry, bone measurements or hormonal endpoints will meet each objective. Document previous treatment and the interval available for a biological response. A short-term change in glucose and a longer-term HbA1c measurement do not represent the same observation window. If a test forms part of the diagnostic definition, evaluating that same test against the definition risks circular reasoning.
The synopsis summarises the question, rationale, objectives, design, population, sample-size basis and essential methods for institutional submission. The protocol provides the operational detail needed to conduct the study, although institutions may use these terms interchangeably.
For endocrinology, both documents should identify the patient's treatment state and the sampling conditions of the main endocrine measurement. The protocol expands these into collection instructions, assay documentation, confirmation of borderline results, handling of interfering medicines and follow-up after therapy changes. A study of thyroid results during acute illness should not be described as measuring established thyroid-disease prevalence unless diagnostic confirmation supports that claim.
Choose one primary endpoint. A prevalence study needs an expected proportion, confidence level and absolute precision; a comparison needs a clinically meaningful difference and expected variability. A correlation study should be sized for a justified association rather than a convenient patient count. Allow for invalid specimens, unavailable confirmation and incomplete follow-up, especially for uncommon endocrine disorders.
Preserve the structure of the observations. Repeated hormone samples, serial clinic measurements and thousands of glucose-sensor readings from one patient are not independent participants. Use participant-level summaries or an appropriate repeated-measures model. Specify how skewed hormone distributions, values below detection limits and missing sensor data will be handled.
Address confounding and interpretation. Consider age, sex, adiposity, disease duration, renal function and treatment when relevant to the causal question. Avoid selecting adjustment variables solely from univariable p-values. Observational comparisons between therapies are vulnerable to differences in prescribing indications, affordability and baseline severity. Report effect sizes and confidence intervals, distinguish prespecified from exploratory analyses and avoid presenting a locally selected diagnostic cut-off as externally validated.
For 2026–2027 admissions, choose a common endocrine problem with sufficient eligible patients, reliable assays and feasible follow-up. Check whether the question needs fasting samples, repeat hormone tests, specialist confirmation or a period of stable treatment. One clearly defined primary outcome is usually more workable than several costly biomarkers collected without a focused hypothesis.
Cross-sectional studies suit contemporaneous associations, cohorts suit subsequent outcomes or change over time, case-control studies can examine selected exposures, and diagnostic-accuracy studies need an appropriate reference assessment. Retrospective studies require records with adequate treatment and sampling information. If treatment is assigned for research, the design and approvals must reflect an intervention rather than routine observational care.
Agree on the population, diagnostic criteria, primary endpoint, sampling conditions, assay platform and treatment status at enrolment. Confirm laboratory costs, specialist support and follow-up requirements. Decide how acute illness, pregnancy where relevant, medication changes, supplements and discordant or borderline results will be handled. The title should describe what the available measurements can establish.
Yes, if the question explicitly concerns that clinical setting and the records support interpretation. Acute illness, stress, sampling time and medicines can alter results. For disease-prevalence questions, define when testing after recovery or further confirmation is needed. An isolated abnormal result during acute illness should not automatically be classified as a chronic endocrine disorder. Missing sampling or treatment information may limit a retrospective study.
The synopsis usually supports institutional review and registration, while the protocol explains detailed study conduct. Follow the institution's terminology and format. Both should agree on diagnostic definitions, sampling conditions, treatment status, primary outcome, sample size and analysis. The protocol additionally specifies laboratory procedures, confirmation pathways and handling of treatment changes.
Obtain Institutional Ethics Committee review and applicable consent or an approved waiver for retrospective records or residual samples. Adult-only studies need no child-assent procedure; if children are included, obtain guardian permission and age-appropriate assent from about seven years, as applicable. A routine-care design should specify no additional radiation, contrast or research-only venepuncture and 0 mL extra research blood. Justify any additional numerical blood-volume and frequency limits, scan, sequence or contrast exposure and obtain approval. Dynamic tests need appropriate supervision and a risk-management plan.
Protect reproductive and genetic information and obtain separate consent for identifiable photographs or video. For imaging, remove identifiers from DICOM headers and any reconstructed facial surfaces; justify a waiver for retrospective PACS use. Escalate critical glucose or electrolyte results, suspected adrenal insufficiency and significant incidental lesions to the treating clinician and endocrinologist without delaying care.
Develop these safeguards using ICMR ethical guidance.
No. Iron-deficiency anaemia can raise HbA1c, shortened red-cell survival can lower it, and haemoglobin-variant effects depend on the assay. Recent transfusion and treatment affecting red-cell turnover also complicate interpretation. Record the method and relevant clinical history, and prespecify how affected participants will be analysed. When HbA1c is unreliable, use an appropriate glucose-based assessment for the study question. A statistical adjustment for haemoglobin alone does not correct every source of distortion.
Check the NGSP guidance on factors affecting HbA1c against the laboratory method used.
Yes, with adaptation. A PhD proposal requires a substantive original contribution beyond the usual MD synopsis. For SCFHS and Saudi Board programmes, the Arab Board of Health Specializations, and DHP-, DHA-, DOH- or MOHAP-linked training programmes, verify the specific curriculum, supervision and local ethics requirements. Where a board research project is mandatory, align the proposal and assessment milestones with that requirement. Do not assume uniform research obligations or dissertation formats across these bodies and linked programmes.
Follow the university or training board deadline after guide agreement and a feasibility review. Obtain required scientific, departmental and ethics approvals before recruitment, research testing or research access to identifiable records. Allow time for assay procurement, repeat confirmation, biological response intervals, follow-up and analysis. The last recruited participant must still have enough time to complete the planned follow-up before submission.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol